XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.1
EPT - Condensed Consolidated Statements of Equity for the three months ended March 31, 2023 and 2022 (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2021   65,248        
Balance at period beginning at Dec. 31, 2021 $ 6,176,508 $ 7 $ 6,915,981 $ (916,833) $ (5,552) $ 182,905
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 78,375     73,254   5,121
Change in fair value of derivatives and amortization of swap settlements 20,083       19,404 679
Change in fair value of marketable debt securities, net 398       385 13
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   84        
Stock option and restricted stock plans, net 16,867   16,867      
Sale of common stock, net (141)   (141)      
Equity based compensation costs 2,463   2,380     83
Changes in the redemption value of redeemable noncontrolling interest (5,072)   (5,014)     (58)
Contributions from noncontrolling interest 125         125
Distributions to noncontrolling interest (7,619)         (7,619)
Redemptions of noncontrolling interest (in shares)   0        
Redemptions of noncontrolling interest (26)   (1)     (25)
Common stock dividends (143,754)     (143,754)    
Balance at period end (in shares) at Mar. 31, 2022   65,332        
Balance at period end at Mar. 31, 2022 6,138,207 $ 7 6,930,072 (987,333) 14,237 181,224
Balance at period beginning (in shares) at Dec. 31, 2022   64,605        
Balance at period beginning at Dec. 31, 2022 5,895,116 $ 6 6,750,076 (1,080,176) 46,466 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 161,594     153,532   8,062
Change in fair value of derivatives and amortization of swap settlements (10,294)       (9,944) (350)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   2        
Stock option and restricted stock plans, net 0          
Sale of common stock, net (72)   (72)      
Equity based compensation costs 5,664   5,472     192
Retirement of common stock, net (in shares)   (437)        
Retirement of common stock, net (95,657)   (95,657)      
Changes in the redemption value of redeemable noncontrolling interest (3,058)   (2,927)     (131)
Distributions to noncontrolling interest (7,977)         (7,977)
Redemptions of noncontrolling interest (in shares)   12        
Redemptions of noncontrolling interest (173)   291     (464)
Common stock dividends (148,286)     (148,286)    
Balance at period end (in shares) at Mar. 31, 2023   64,182        
Balance at period end at Mar. 31, 2023 $ 5,796,857 $ 6 $ 6,657,183 $ (1,074,930) $ 36,522 $ 178,076